Electronic Data Capture Systems Market Size, Trends, Share, Growth | Report 2022-2030
The global electronic data capture systems market was estimated at USD 587.52 million in 2021 and it is expected to surpass around USD 1.83 billion by 2030, poised to grow at a CAGR of 13.46% from 2022 to 2030
The rising demand for software solutions in clinical trials, increasing R&D expenditure by companies in healthcare, supportive government initiatives to boost trials, and increasing number of potential customers implementing Electronic Data Capture (EDC) systems are some of the key factors contributing to the market growth.
The market is growing rapidly owing to the technological advancements in eClinical solutions and this is anticipated to serve this industry with future growth opportunities. Furthermore, increasing awareness pertaining to EDC solutions is predicted to fuel the demand in near future. Moreover, government organizations such as Agency for Healthcare Research and Quality and The Office of National Coordinator for Health Information Technology are promoting the adoption of electronic systems for data management. The aforementioned factors have resulted in the rising adoption of electronic data collection by pharmaceutical companies.
Moreover, increasing adoption of EDC systems by major pharmaceuticals to propagate clinical trials is predicted to provide this market with lucrative growth. For instance, in May 2016, Simbec-Orion Group selected Oracle's product, the Siebel Clinical Trial Management System, to strengthen its development processes and to expand its international operations & business. The system will provide efficient data capture and speed up the trial timelines. The strategies like this are anticipated to boost demand in coming years.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 587.52 million |
| Revenue Forecast by 2030 | USD 1.83 billion |
| Growth rate from 2022 to 2030 | CAGR of 13.46% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Component, delivery mode, development phase, end-use, Region |
| Companies Covered | Medidata Solutions, Inc.; Oracle Corporation; BioClinica; Parexel International Corporation; Datatrak International, Inc.; Medidata Solutions, Inc.; eClinical Solutions; Merge Healthcare, Inc.; OmniComm Systems, Inc.; Acceliant; Clinipace, Inc.; Openclinica, LLC |
Component Insights
Services for the EDC systems held the largest market share as of 2021, owing to the availability of a large number of Contract Research Organizations (CROs) offering the eClinical solutions. This is due to the increasing scrutiny from regulatory bodies to meet the complex regulatory requirements of clinical trials, which is anticipated to contribute toward the growing demand over the forecast period.
The software segment is anticipated to witness lucrative growth soon due to rising adoption by manufacturers to curb growing expenditure on data management. The associated benefits of using EDC systems, such as timesaving and simpler regulatory processes, are presumed to boost the adoption in the coming years.
Delivery Mode Insights
Depending on the current level of implementation and future growth prospects, cloud-based delivery systems for EDC services are expected to register the highest demand in near future. This exponential growth rate is a consequence of increasingly being recognized to provide greater efficiency in numerous applications, such as the trial design stage, data collection processes, and monitoring & report generation.
On the other hand, the web-based portal holds the largest share in the delivery mode segment, owing to the high data maintenance cost involved in clinical trials, which has increased dramatically. These high costs are presumed to contribute to the high reluctance of pharmaceutical companies, thus restricting them to invest in expensive studies and focus on relatively inexpensive alternatives for information management, such as web-based portals.
Development Phase Insights
In the development phase segment, Phase III held a substantial share in 2021 owing to the high requirement for EDC software to curb the overall cost and improve the efficiency of processes. On the other hand, Phase I is presumed to grow with a lucrative growth rate soon as a consequence of the high significance of these systems in predicting future outcomes and eliminating drug candidates with a low probability of success in the clinical trials.
A large number of phase I trials and complex management and analysis processes of the information acquired during various studies have been boosting the demand for the computer-assisted solutions. The currently available tools have enabled minimization of manual errors and have increased the efficiency by cutting huge costs incurred through bypassing the processes of manual sourcing, transcribing, and double data entry. Direct data and remote information capturing are the factors aiding the rising popularity of these components during the forecast period. The integration of EDC systems is expected to result in a lowering of the prices for data management, which is anticipated to boost the market in the developing regions.
End-use Insights
CROs held the largest market share and are anticipated to exhibit the fastest growth as a consequence of the rising inclination of pharmaceutical companies toward reducing overall expenditure and involved benefits, which are anticipated to be responsible for the heightened growth.
The benefits primarily include cost-effectiveness, increased efficiency of services, enhanced compatibility, and a higher focus on the core areas of development that are critical to a company's growth. Clinical information management involves clinical data processing by using a range of computer applications and support services.
Regional Insights
North America held the largest market share as of 2021 owing to the presence of higher awareness levels and stringent regulatory norms about the handling of clinical information. Besides, the presence of major pharmaceutical companies in this region is anticipated to boost the adoption of EDC systems over the forecast period.
Asia Pacific market for EDC systems is presumed to witness lucrative growth soon due to the presence of a large number of CROs offering eClinical solutions to large pharmaceutical companies.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Electronic Data Capture Systems Market
5.1. COVID-19 Landscape: Electronic Data Capture Systems Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Electronic Data Capture Systems Market, By Component
8.1. Electronic Data Capture Systems Market, by Component, 2022-2030
8.1.1. Software
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Services
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Electronic Data Capture Systems Market, By Delivery Mode
9.1. Electronic Data Capture Systems Market, by Delivery Mode e, 2022-2030
9.1.1. Web-hosted
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Licensed enterprise
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Cloud-based
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Electronic Data Capture Systems Market, By Development Phase
10.1. Electronic Data Capture Systems Market, by Development Phase, 2022-2030
10.1.1. Phase I
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Phase II
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Phase III
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Phase IV
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Electronic Data Capture Systems Market, By End-use
11.1. Electronic Data Capture Systems Market, by End-use, 2022-2030
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. CROs
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Academic institutes
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Pharma & Biotech Organizations
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Medical Device Manufacturers
11.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Electronic Data Capture Systems Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Component (2017-2030)
12.1.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.1.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.1.4. Market Revenue and Forecast, by End-use (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.2.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.2.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.3.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.3.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.4.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.4.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End-use (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.5.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.5.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Development Phase (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 13. Company Profiles
13.1. Medidata Solutions, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Oracle Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. BioClinica
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Parexel International Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Datatrak International, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Medidata Solutions, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. eClinical Solutions
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Merge Healthcare, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. OmniComm Systems, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Acceliant
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers